| Literature DB >> 27103935 |
Shawn D Youngstedt1, Christopher E Kline2, Jeffrey A Elliott3, Mark R Zielinski4, Tina M Devlin5, Teresa A Moore6.
Abstract
Limited research has compared the circadian phase-shifting effects of bright light and exercise and additive effects of these stimuli. The aim of this study was to compare the phase-delaying effects of late night bright light, late night exercise, and late evening bright light followed by early morning exercise. In a within-subjects, counterbalanced design, 6 young adults completed each of three 2.5-day protocols. Participants followed a 3-h ultra-short sleep-wake cycle, involving wakefulness in dim light for 2h, followed by attempted sleep in darkness for 1 h, repeated throughout each protocol. On night 2 of each protocol, participants received either (1) bright light alone (5,000 lux) from 2210-2340 h, (2) treadmill exercise alone from 2210-2340 h, or (3) bright light (2210-2340 h) followed by exercise from 0410-0540 h. Urine was collected every 90 min. Shifts in the 6-sulphatoxymelatonin (aMT6s) cosine acrophase from baseline to post-treatment were compared between treatments. Analyses revealed a significant additive phase-delaying effect of bright light + exercise (80.8 ± 11.6 [SD] min) compared with exercise alone (47.3 ± 21.6 min), and a similar phase delay following bright light alone (56.6 ± 15.2 min) and exercise alone administered for the same duration and at the same time of night. Thus, the data suggest that late night bright light followed by early morning exercise can have an additive circadian phase-shifting effect.Entities:
Keywords: 6-sulphatoxymelatonin; additive effect; humans; ultra-short sleep wake cycle; young adults
Year: 2016 PMID: 27103935 PMCID: PMC4834751 DOI: 10.5334/jcr.137
Source DB: PubMed Journal: J Circadian Rhythms ISSN: 1740-3391
Demographic information about the participants.
| Men (n = 3) | Women (n = 3) | |
|---|---|---|
| Age (yr) | 23.7 ± 3.2 | 20.7 ± 1.2 |
| Height (cm) | 172.7 ± 7.6 | 159.2 ± 5.3 |
| Weight (kg) | 66.2 ± 9.3 | 53.7 ± 2.6 |
| Beck Depression Inventory | 2.0 ± 1.7 | 1.0 ± 1.7 |
| Horne-Ostberg | 53.8 ± 9.3 | 59.3 ± 0.6 |
| Morningness-Eveningness Questionnaire | Intermediate | Intermediate |
| Usual Sleep Duration (min) | 450 ± 52.2 | 410.0 ± 45.8 |
Figure 1Experimental protocol: evening bright light followed by early morning exercise. Participants adhered to an ultra-short sleep-wake cycle beginning at 1600 h on Friday, and were subsequently exposed to 90 min of bright light (5000 lux, 2210–2340 h) followed 4.33 h later by 90 min of exercise (0410–0540 h). In the other two treatments, subjects received bright light alone or exercise alone at 2210–2340 h. Phase shifts of the aMT6s rhythm were calculated by subtracting final post treatment acrophase from baseline acrophase.
Figure 224-h rhythms of aMT6s Excretion at baseline and after treatment. Individual urinary 6-sulphatoxymelatonin data (aMT6s) were averaged into 90-min bins, normalized to percent of peak, and group means (+/– SEM, N = 6) plotted on a 12 noon to 12 noon axis to yield synchronized 24-h profiles representing rhythm timing and waveform at baseline (●) and post-treatment (ο). Color-filled rectangles represent the timing of light and exercise stimuli (light: yellow; exercise: blue). Color filled diamonds underneath the curves represent mean acrophase times before (green) and after (red) treatment. ANOVAs for the normalized 90-min time series (panels A,B,C) underscored robust 24-h rhythmicity [p’s < 0.001] and confirmed a significant phase shift (interaction) for the Light + Exercise treatment, but not for the other treatments.
aMT6s baseline, timing of treatments, and phase shifts in the aMT6s acrophase for the individual participants.
| Subject | Bright Light | Exercise | Bright Light + Exercise | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Base aMT6s Acrophase | Timing: After Phase (h:min) | aMT6s Acrophase Delay (min) | Base aMT6s Acrophase | Timing: After Phase (h:min) | aMT6s Acrophase Delay (min) | Base aMT6s Acrophase | Timing After Acrophase for Light & Exercise | aMT6s Acrophase Delay (min) | |
|
| |||||||||
| 01 | 0137 h | –2:41 | –71 | 0244 h | –3:49 | –39 | 0205 h | –3:10 & +2:50 | –64 |
| 02 | 0419 h | –5:24 | –79 | 0410 h | –5:15 | –34 | 0440 h | –5:44 & +0:16 | –74 |
| 03 | 0147 h | –2:52 | –55 | 0115 h | –2.20 | –89 | 0244 h | –3:49 & +2:71 | –85 |
| 04 | 0443 h | –5:48 | –46 | 0438 h | –5:43 | –30 | 0426 h | –5:31 & +0:29 | –83 |
| 05 | 0619 h | –7:24 | –43 | 0538 h | –6:43 | –48 | 0503 h | –6:08 & -0:08 | –98 |
| 06 | 0345 h | –4:50 | –45 | 0302 h | –4:07 | –43 | 0313 h | –4:18 & 1:42 | –81 |
Figure 3Phase delays in aMT6s acrophase were greatest with light followed by exercise. The bar graph contrasts the group mean (-SEM, n = 6) phase delay shifts observed in aMT6s rhythm 24-h cosine acrophases determined pre- vs. post-stimulation in the three treatments [Bright Light (BL); Exercise (EX); and Bright Light + Exercise (L+E)]. ANOVA revealed that the phase delay following L + E was significantly greater than that following EX. Other comparisons were not significant.
Mean aMT6s data across the six participants.
| Treatment | Baseline aMT6s Acrophase (h) | Baseline CRQ Amplitude/Mesor | Stimulus Timing: H After Baseline Acrophase | Final aMT6s Acrophase (hr:min) | Final CRQ | aMT6s Phase Shift min |
|---|---|---|---|---|---|---|
| Bright Light | 0345 ± 1:48 | 1.22 ± 0.08 | –4.83 ± 1.81 | 0442 ± 1:43 | 1.29 ± 0.13 | –56.6 ± 15.2 |
| Exercise | 0335 ± 1:33 | 1.21 ± 0.16 | –4.66 ± 1.56 | 0422 ± 1:20 | 1.24 ± 0.12 | –47.3 ± 21.6 |
| Bright Light + Exercise | 0342 ± 1:11 | 1.24 ± 0.11 | Light: –4.78 ± 1.19 | 0503 ± 1:19 | 1.31 ± 0.10 | –80.8 ± 11.6 |